Acceptance and Hesitancy of Covid-19 Vaccine among Pregnant Women Attending Antenatal Care Clinic at Makongoro Hospital, Mwanza-Tanzania.
Material type:
TextPublisher number: Phone: +255 28 298 3384 Fax: +255 28 298 3386 Email: vc@bugando.ac.tz Website: www.bugando.ac.tz Language: English Language: Kiswahili Publication details: Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS – Bugando] : ©2023Description: 52 Pages; Includes References and AppendiciesSubject(s): Summary: Abstract:
Introduction and Problem Statement: Corona virus diseases 2019 (COVID-19) is a respiratory tract infection that is caused by a novel coronavirus (SARS-CoV-2) that emerged in December 2019 in Wuhan, China. Pregnant women had an increased risk of developing worse pregnancy outcomes like preeclampsia, preterm delivery, gestational diabetes and low birth weight in pregnancy (1). The main reasons for very low vaccine acceptance are the fear of side effects and lack of confidence in vaccine effectiveness.
Objective: Assessing the acceptance and hesitancy level of COVID-19 vaccine among pregnant women attending ANC Clinic at Makongoro Hospital, Mwanza-Tanzania.
METHODS: A hospital-based cross-sectional was conducted among 321 pregnant women attending ANC at Makongoro Hospital who voluntarily consented to participate in the study.
Results: All participants have ever been vaccinated before in life aside from the COVID-19 vaccine and among them only 11.2% got complications after the vaccination. Among all participants, only 32.7% received a COVID-19 vaccine and 42.1% of all participants believe that COVID-19 vaccines could harm them and their babies. 62.6% of all participants believed that vaccines are important for their health and 52.3% believed that COVID-19 vaccines are effective while 29% believed that new vaccines including COVID-19 vaccines carried more risks than older vaccines. 77.9% of the participants were concerned about serious adverse effects of vaccines.
Conclusion: Participants in their first trimester expressed greater interest in receiving the COVID-19 vaccination compared with participants in their second and third trimesters (p<0.05) in which the results were consistent with the results of the study conducted by Sule Goncu et al (2). The greatest concern about the COVID-19 vaccine among the hesitant pregnant women was a lack of data about safety in the pregnant population consistent with the study conducted in the United States in December 2020 by Sara E. Oliver et al(3). The main barriers that contributed to vaccine hesitancy in this study were the fear of the safety and side effects of the vaccine, its effectiveness and the fast pace of the vaccine’s development, as compared to other common vaccines, this is consistent with the study conducted in 2021 by Fidelia Cascini et al (4).
| Item type | Current library | Collection | Status | Barcode | |
|---|---|---|---|---|---|
| UNDERGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | 1 | CUHAS/MD/4002581/T/1 |
Abstract:
Introduction and Problem Statement: Corona virus diseases 2019 (COVID-19) is a respiratory tract infection that is caused by a novel coronavirus (SARS-CoV-2) that emerged in December 2019 in Wuhan, China. Pregnant women had an increased risk of developing worse pregnancy outcomes like preeclampsia, preterm delivery, gestational diabetes and low birth weight in pregnancy (1). The main reasons for very low vaccine acceptance are the fear of side effects and lack of confidence in vaccine effectiveness.
Objective: Assessing the acceptance and hesitancy level of COVID-19 vaccine among pregnant women attending ANC Clinic at Makongoro Hospital, Mwanza-Tanzania.
METHODS: A hospital-based cross-sectional was conducted among 321 pregnant women attending ANC at Makongoro Hospital who voluntarily consented to participate in the study.
Results: All participants have ever been vaccinated before in life aside from the COVID-19 vaccine and among them only 11.2% got complications after the vaccination. Among all participants, only 32.7% received a COVID-19 vaccine and 42.1% of all participants believe that COVID-19 vaccines could harm them and their babies. 62.6% of all participants believed that vaccines are important for their health and 52.3% believed that COVID-19 vaccines are effective while 29% believed that new vaccines including COVID-19 vaccines carried more risks than older vaccines. 77.9% of the participants were concerned about serious adverse effects of vaccines.
Conclusion: Participants in their first trimester expressed greater interest in receiving the COVID-19 vaccination compared with participants in their second and third trimesters (p<0.05) in which the results were consistent with the results of the study conducted by Sule Goncu et al (2). The greatest concern about the COVID-19 vaccine among the hesitant pregnant women was a lack of data about safety in the pregnant population consistent with the study conducted in the United States in December 2020 by Sara E. Oliver et al(3). The main barriers that contributed to vaccine hesitancy in this study were the fear of the safety and side effects of the vaccine, its effectiveness and the fast pace of the vaccine’s development, as compared to other common vaccines, this is consistent with the study conducted in 2021 by Fidelia Cascini et al (4).
There are no comments on this title.
Click on an image to view it in the image viewer